Presentation at the WECAN Academy 2019:
Pre-approval access: to clinical trials (including cross-border, pre-approval, post-approval, and advocacy action
Presenter: Bettina Ryll, Melanoma Patients Network Europe & Holly Lumgair, Clinigen & Gilly Spurrier, Melanoma Patients Network Europe & Violeta Astratinei, Melanoma Patients Network Europe
The following presentation held at the WECAN Academy 2019 will help you to understand:
- Why this is important – including the analysis of access issues that a patient advocacy group faces
- Overview of Early Access mechanisms, how they work, the main areas to consider, including the possibilities and the challenges.
- Perspective on access to clinical trials
- Introduction to the situation about CEE access, especially when it comes to ways to manage funding issues
0305 Spurrier – Ryll – Astratinei – Early access to new therapies spurrier – ryll – astratinei from WECANWorkgroup
Leave A Comment